David E. Martin PhD is the developer of several innovation-based quantitative indices of public equities and founder of the Purple Bridge Funds and M-CAM International. He has worked closely with the United States Congress and numerous trade and financial regulatory agencies in the United States. Dr. Martin is also a Batten Fellow at the University of Virginia's Darden Graduate School of Business Administration. Since 1999, Dr. Martin has been actively tracking patent applications and approvals for the purpose of identifying suspicious activity. In the 94-minute video shown below, he shares the findings from his research regarding the laboratory development of a pathogenic coronavirus that started in 1999 and released initially upon human populations in the SARS CoV-1 in 2002-2003, then again in MERS (Middle East Respiratory Syndrome in 2012, and then again in SARS CoV-2 which was renamed COVID-19, as shown below with evidence from the primary development lab in Wuhan China. In my o...